Matthew Buten

Officer, Biohaven Pharmaceutical Holding Co Ltd.

Companies

Biohaven PharmaceuticalsChief financial officer Oct 5, 2022 to now¹
Biohaven Pharmaceutical Holding Co Ltd.Chief financial officer Jan 4, 2022 to Oct 3, 2022²
Biohaven PharmaceuticalsTreasurer Sep 28, 2022 to Sep 28, 2022³
Biohaven Pharmaceutical Holding Co Ltd.Officer Dec 14, 2021 to Dec 14, 2021⁴

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 5, 2026Shares withheld for tax 2,594 shares at $9.93 of Biohaven Pharmaceuticals⁵
Jan 5, 2026Exercised options 4,250 shares of Biohaven Pharmaceuticals⁵
Jan 5, 2025Shares withheld for tax 2,561 shares at $38.64 of Biohaven Pharmaceuticals⁷
Jan 5, 2025Exercised options 4,250 shares of Biohaven Pharmaceuticals⁷
Oct 5, 2023Bought 22,727 shares at $22.00 of Biohaven Pharmaceuticals⁸
Oct 25, 2022Bought 142,857 shares at $10.50 of Biohaven Pharmaceuticals⁹
Oct 3, 2022Shares withheld for tax 11,042 shares at $7.50 of Biohaven Pharmaceuticals¹⁰
Oct 3, 2022Exercised options 11,450 shares at $6.37 of Biohaven Pharmaceuticals¹⁰
Oct 3, 2022Exercised options 1,550 shares at $6.37 of Biohaven Pharmaceuticals¹⁰
Oct 3, 2022Other 18,750 shares of Biohaven Pharmaceuticals¹⁰
Oct 3, 2022Returned to company 6,177 shares at $148.50 of Biohaven Pharmaceutical Holding Co Ltd.⁶
Oct 3, 2022Other 3,088 shares of Biohaven Pharmaceuticals¹⁰
Dec 31, 2021Shares withheld for tax 6,323 shares at $137.81 of Biohaven Pharmaceutical Holding Co Ltd.¹¹
Dec 31, 2021Exercised options 12,500 shares of Biohaven Pharmaceutical Holding Co Ltd.¹¹

The numbers on this page point here. Each one links to the record it came from.